Patients underwent electrocoagulation ablation therapy and were placed on high dose proton pump inhibitors (acid suppressors). Complete eradication of Barrett’s esophagus was achieved between one and five sessions. The researchers found 95 percent of patients had no recurrence of Barrett’s esophagus after initial ablation, and no adenocarcinoma or high-grade dysplasia of the esophagus developed in any of the patients.
The authors conclude that multipolar electrocoagulation is a safe, effective technique for ablating Barrett’s esophagus over the long term.
Read the ASGE release on Barrett’s esophagus (pdf).
Read more coverage on GI issues:
– Office Desk Jobs Double Colon Cancer Risk
– Local Washington Health Board Reverses Approval of Colonoscopy Campaign
– Coverage of Preventive Services Under New Healthcare Law Causing Confusion
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
